{
    "2018-08-09": [
        [
            {
                "time": "2018-08-09",
                "original_text": "【西南医药朱国广团队】恒瑞医药（600276）收入增长加速，创新品种陆续获批",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "收入增长",
                        "创新品种",
                        "获批"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "恒瑞卡培他滨「不通过」一致性评价？",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "卡培他滨",
                        "一致性评价",
                        "不通过"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "华鲁恒升上半年净利增逾2倍 多家公司公布业绩",
                "features": {
                    "keywords": [
                        "华鲁恒升",
                        "净利",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "恒瑞医药：上半年净利润同比增21%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "8月9日复盘:藏三大积极信号 主力重点出击17股(名单)",
                "features": {
                    "keywords": [
                        "复盘",
                        "积极信号",
                        "主力出击"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "渤海证券医药行业周报：牢牢把握业绩主线",
                "features": {
                    "keywords": [
                        "渤海证券",
                        "医药行业",
                        "业绩主线"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "[强烈推荐评级]新宙邦(300037)事件点评报告：新增外延项目 业绩持续高增",
                "features": {
                    "keywords": [
                        "新宙邦",
                        "外延项目",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}